Bio Expo Online / Name Reactions / Gomberg-Bachmann reaction
Aesica Pharmaceuticals Limited
Our state-of-the-art technology offers the capability to manufacture development compounds in quantities for use in Phase I to III clinical trials or for high volume continuous supplies. We will carry out all your IND/CMC requirements from the preclinical stage right through to commercial supply.
Thirty technologies are the basis for AllessasChemie’s product range of 700 organic intermediates. Together with AllessaSyntec, the scale-up from laboratory to technical scale to 50 tons per year can be provided.